Imagen de Portada
Código QR

Combined AD Tx shows promise.

Publicado en:Dermatology Times Vol. 39; no. 10; pp. 34 - 36
Autor principal: KRONEMYER, BOB
Formato: Journal Article
Publicado: MJH Life Sciences Oct2018
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=132756262&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 132756262
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        01966197
        DTI
      jtl: Dermatology Times
      issn: 01966197
      maglogo: N
    pubinfo:
      dt: Oct2018
      vid: 39
      iid: 10
      pid: 54670
      pub: MJH Life Sciences
      place: Cranbury, New Jersey
    artinfo:
      ui:
        132756262
        132756262
      ppf: 34
      ppct: 2
      formats:
      tig:
        atl: Combined AD Tx shows promise.
      aug:
        au: KRONEMYER, BOB
      sug:
        subj:
          Dermatitis, Atopic Drug Therapy
          Antibodies, Monoclonal Therapeutic Use
          Adrenal Cortex Hormones Administration and Dosage
          Adrenal Cortex Hormones Therapeutic Use
          Administration, Topical
          Depression Prevention and Control
          Quality of Life
          Antibodies, Monoclonal Adverse Effects
          Conjunctivitis Chemically Induced
      pubtype: Trade Publication
      doctype: Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N